Journal of Neurovirology

Papers
(The median citation count of Journal of Neurovirology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Combined effects of older age and HIV disease on changes in everyday functioning over one year113
Exacerbation of diabetic neuropathy can mimic SARS-CoV-2 associated pure dysautonomic Guillain–Barre syndrome100
Risk factors of herpes simplex virus reactivation after surgery for primary trigeminal neuralgia43
Difference in the neurocognitive functions of WLWH and MLWH in an Italian cohort of people living with HIV37
HIV-related drivers of sexual compulsivity and sexuality in sexual minority men who use methamphetamine30
Main lymphocyte subpopulations in cerebrospinal fluid and peripheral blood in HIV-1 subtypes C and B29
Herpesvirus encephalitis diagnosed by polymerase chain reaction at the National Institute of Neurology of Mexico27
Possible role of CNS microRNAs in Human Mpox virus encephalitis—a mini-review25
Metagenomic search of viral coinfections in herpes simplex encephalitis patients21
Cytomegalovirus infection induces Alzheimer’s disease-associated alterations in tau18
Psychometric utility of the international HIV dementia scale and Montreal Cognitive Assessment in HIV-associated asymptomatic neurocognitive impairment16
Unexpected worsening of progressive multifocal leucoencephalopathy following COVID-19 pneumonia16
Detection of SARS-coronavirus-2 in the central nervous system of patients with severe acute respiratory syndrome and seizures15
Detection of human neurotropic JCPyV DNA sequence in pediatric anaplastic xanthoastrocytoma15
Differences in neuroinflammation in people who started antiretroviral treatment during primary versus chronic HIV infection: an 18kDa Translocator protein (TSPO) positron emission tomography (PET) stu15
Implications of vascular depression for successful cognitive aging in HIV Disease14
Catastrophic tumefactive acute disseminated encephalomyelitis in patient with dengue virus: a case report14
Correction to: The anti-cancer drug Sunitinib promotes autophagy and protects from neurotoxicity in an HIV-1 Tat model of neurodegeneration. Journal of NeuroVirology 201713
Monitoring of HTLV-1-associated diseases by proviral load quantification using multiplex real-time PCR13
A fulminant case of Epstein-Barr Virus encephalitis with multiorgan dysfunction13
Substance use moderates relationships between apolipoprotein E genotype, hepatitis C, cognition, and depression in Miami Adult Studies on HIV (MASH) participants13
Limited evidence for a moderating effect of HIV status on brain age in heavy episodic drinkers13
Characterizing Epstein-Barr virus infection of the central nervous system in Zambian adults living with HIV12
Is there a connection between neurocognitive profile in treatment naïve non-cirrhotic HCV patients and level of systemic inflammation?12
Does antiretroviral therapy alter the course of Parkinson’s disease in people living with HIV?11
Mitochondrial DNA haplogroups and domain-specific neurocognitive performance in adults with HIV11
MicroRNA expression profiling of cerebrospinal fluid/serum exosomes in children with human herpesvirus 6-associated encephalitis/encephalopathy by high-throughput sequencing11
HIV-1 mRNA knockdown with CRISPR/CAS9 enhances neurocognitive function10
Altered white matter microstructure and neurocognitive function of HIV-infected patients with low nadir CD410
Reactivation of varicella zoster virus following trigeminal schwannoma resection10
Opsoclonus myoclonus ataxia syndrome in severe acute respiratory syndrome coronavirus-210
Zika virus infection of retinal cells and the developing mouse eye induces host responses that contrasts to the brain and dengue virus infection10
Generating fair, reliable, and accurate neuropsychological test norms for people with HIV in a low- or middle-income country9
Meningitis associated with HHV-7 in an Iranian immunocompetent adolescent girl9
Innate immune memory in chronic HIV and HIV-associated neurocognitive disorders (HAND): potential mechanisms and clinical implications9
Chronic SSRI treatment reverses HIV-1 protein-mediated synaptodendritic damage9
Human endogenous retrovirus W in multiple sclerosis: transcriptional activity is associated with decline in oligodendrocyte proportions in the white matter of the brain8
Post-COVID-19 olfactory dysfunction: carbamazepine as a treatment option in a series of cases8
Varicella zoster virus infection in neurological patients in Bulgaria8
Successful treatment of HIV-associated progressive multifocal leukoencephalopathy (PML) with mirtazapine, mefloquine, and IVIG combination therapy: a case report8
Neuropathies and neurological dysfunction induced by coronaviruses8
iPSC-derived three-dimensional brain organoid models and neurotropic viral infections7
Correlation between cerebrospinal fluid and plasma neurofilament light protein in treated HIV infection: results from the COBRA study7
A pilot study of cognition and creativity among persons with HIV disease referred for neuropsychological evaluation7
Relationship of the balloon analog risk task to neurocognitive impairment differs by HIV serostatus and history of major depressive disorder7
Caffeine upregulates SIRT3 expression to ameliorate astrocytes-mediated HIV-1 Tat neurotoxicity via suppression of EGR1 signaling pathway7
Cortico-striatal networking deficits associated with advanced HIV disease and cocaine use7
TCA cycle metabolic compromise due to an aberrant S-nitrosoproteome in HIV-associated neurocognitive disorder with methamphetamine use7
Correction to: Plasma extracellular vesicles and cell-free mitochondrial DNA are associated with cognitive dysfunction in treated older adults with HIV7
A frantic confusion: beyond rabies and anti-N-methyl-D-aspartate encephalitis7
Rapid-progressing progressive multifocal leukoencephalopathy in two patients newly diagnosed with HIV: case series and review of literature6
Dengue fever presenting as acute cerebellar ataxia: Case report and literature review6
Untreated herpes simplex virus encephalitis without a fatal outcome6
Longitudinal, virological, and serological assessment of hospitalized COVID-19 patients6
Additive cortical gray matter deficits in people living with HIV who use cocaine6
Serum mir-142-3p release in children with viral encephalitis and its relationship with nerve injury and inflammatory response6
Plasma anti-CD4 IgG is associated with brain abnormalities in people with HIV on antiretroviral therapy6
Improved neurocognitive performance in FIV infected cats following treatment with the p75 neurotrophin receptor ligand LM11A-316
Effects of cocaine and HIV on decision-making abilities6
SARS-CoV and SARS-CoV-2 display limited neuronal infection and lack the ability to transmit within synaptically connected axons in stem cell–derived human neurons6
Associations of alcohol use, HIV infection, and age with brain white matter microstructure6
Viruses, SUMO, and immunity: the interplay between viruses and the host SUMOylation system6
Assessment, prevalence, and correlates of frailty among middle-aged adults with HIV in rural Uganda6
The incidence of symptomatic CSF viral escape in patients on antiretroviral therapy in western India: a retrospective cohort study6
Progressive multifocal leukoencephalopathy: a retrospective study of the last 12 years in a tertiary-care hospital5
Ependymal restricted diffusion and injury to the olfactory system on a ventriculoencephalitis associated with COVID-195
Neurological soft signs and brain morphology in people living with HIV5
Microglia proliferation underlies synaptic dysfunction in the prefrontal cortex: implications for the pathogenesis of HIV-1-associated neurocognitive and affective alterations5
Using plasma proteomics to investigate viral infections of the central nervous system including patients with HIV-associated neurocognitive disorders5
Neuropsychological profile of patients with infectious disease: characterization and comparison of patients with HIV, HTLV, and HCV5
Evaluation of the effects of the Zika Virus-Immunoglobulin G+ complex on murine microglial cells5
HSV-1 latency-associated transcript miR-H3 and miR-H4 target STXBP1 and GABBR2 genes5
Undetectable JC virus CSF PCR in patients with JC virus-induced progressive multifocal leukoencephalopathy5
Mild encephalitis/encephalopathy with a reversible splenial lesion associated with respiratory syncytial virus infection in infants5
Notes from guest editor Dr. Fatah Kashanchi5
HIV peripheral neuropathy‐related degeneration of white matter tracts to sensorimotor cortex5
Altered expression of fractalkine in HIV-1-infected astrocytes and consequences for the virus-related neurotoxicity4
Cognitive function and impact on driving after SARS-COV-2 infection in a man with long-standing HIV infection: a case report4
Understanding the link between neurotropic viruses, BBB permeability, and MS pathogenesis4
MRI negative myelopathy post mild SARS-CoV-2 infection: vasculopathy or inflammatory myelitis?4
“Anosmia” the mysterious collateral damage of COVID-194
Regulation of voltage-gated sodium channels by TNF-α during herpes simplex virus latency establishment4
Coronavirus infection in chemosensory cells4
Molecular epidemiology of enteroviruses and predominance of echovirus 30 in an Iranian population with aseptic meningitis4
Cerebral vasculitis caused by Talaromyces marneffei and Aspergillus niger in a HIV-positive patient: a case report and literature review4
Myelin regulatory factor is a target of individual and interactive effects of HIV-1 Tat and morphine in the striatum and pre-frontal cortex4
Clinical use of steroids in viral central nervous system (CNS) infections: three challenging cases4
Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients4
Coronavirus disease (COVID-19) complicated by rhino-orbital-cerebral mucormycosis presenting with neurovascular thrombosis: a case report and review of literature4
Stroke risk after varicella-zoster virus infection: a systematic review and meta-analysis4
Multiple demyelinating sensory and motor mononeuropathy associated with COVID-19: a case report3
HIV-1 and methamphetamine alter galectins -1, -3, and -9 in human monocyte-derived macrophages3
Varicella-zoster virus meningitis coincident with bacteremia caused by liver abscess: a case report3
Illuminating the in vitro effects of Epstein-Barr virus and vitamin D on immune response in multiple sclerosis patients3
SARS-CoV-2–associated Guillain–Barre syndrome requires extensive pre- and post-mortem examinations3
Effects of unhealthy alcohol use on brain morphometry and neurocognitive function among people with HIV3
Circulating endothelial and angiogenic cells predict hippocampal volume as a function of HIV status3
Correction: Interaction of declined handgrip strength and HIV infection on neurocognitive impairment3
Progressive multifocal leukoencephalopathy in sarcoidosis successfully treated with pembrolizumab3
Clinical and magnetic resonance imaging patterns of extensive Chikungunya virus–associated myelitis3
Revisiting JC virus and progressive multifocal leukoencephalopathy3
Encephalomyelitis in a patient with monkeypox: an unusual complication3
The impacts of HIV infection, age, and education on functional brain networks in adults with HIV3
Cognitive dysfunction following COVID-19 infection3
Tryptophan-kynurenine metabolic pathway and daytime dysfunction in women with HIV3
Clinical characteristics and outcomes of COVID-19-associated encephalopathy in children3
Optic neuritis following SARS-CoV-2 infection3
RNA-Seq time-course analysis of neural precursor cell transcriptome in response to herpes simplex Virus-1 infection3
Emergence of myasthenia gravis in dengue infection—first case report3
Characteristics of taste dysfunction in COVID-19 subjects coming from two different countries3
Compassionate-use pocapavir and immunoglobulin therapy for treatment of rituximab-associated enterovirus meningoencephalitis3
The relationship between vascular endothelial growth factor (VEGF) and amnestic mild cognitive impairment among older adults living with HIV3
Differential expression of cellular prion protein (PrPC) in mouse hepatitis virus induced neuroinflammation3
Delayed post-hypoxic leukoencephalopathy in an adult with COVID-193
Higher buccal mitochondrial DNA and mitochondrial common deletion number are associated with markers of neurodegeneration and inflammation in cerebrospinal fluid3
Serum of COVID-19 patients changes neuroinflammation and mitochondrial homeostasis markers in hippocampus of aged rats3
Progressive multifocal leukoencephalopathy associated with systemic lupus erythematosus: longitudinal observation of lymphocytes, JC virus in cerebrospinal fluid, and brain magnetic resonance imaging3
Response to “a fatal case of Guillain-Barré syndrome after infection with COVID-19”3
The relationship between synaptodendritic neuropathology and HIV-associated neurocognitive disorders is moderated by cognitive reserve3
Cerebrospinal fluid levels of 5-HIAA and dopamine in people with HIV and depression3
Correction: Role of inflammatory cytokine burst in neuro-invasion of Japanese Encephalitis virus infection: an immunotherapeutic approaches3
Correction: Tat expression led to increased histone 3 tri-methylation at lysine 27 and contributed to HIV latency in astrocytes through regulation of MeCP2 and Ezh2 expression3
Suppression of HIV-TAT and cocaine-induced neurotoxicity and inflammation by cell penetrable itaconate esters3
Potential mechanisms of cerebrovascular diseases in COVID-19 patients3
CD4 nadir and neurocognitive trajectories in people living with HIV3
Long-term survival from progressive multifocal leukoencephalopathy in living-donor liver transplant recipient with preformed donor-specific antibody2
Momordica charantia phytoconstituents can inhibit human T-lymphotropic virus type-1 (HTLV-1) infectivity in vitro and in vivo2
Meta-analysis of the serum/plasma proteome identifies significant associations between COVID-19 with Alzheimer’s/Parkinson’s diseases2
Correction to: TCA cycle metabolic compromise due to an aberrant S‑nitrosoproteome in HIV‑associated neurocognitive disorder with methamphetamine use2
Advances in HIV therapeutics and cure strategies: findings obtained through non-human primate studies2
Detection of disease-associated microglia among various microglia phenotypes induced by West Nile virus infection in mice2
Central nervous system vasculopathy associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a novel case report from Iran2
A case of progressive multifocal leukoencephalopathy with hypogammaglobulinemia and a TCF3 mutation2
Risk factors for neurological complications in children with Flavivirus infection2
Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy in China2
Monkeypox virus replication underlying circadian rhythm networks2
Systematic post-mortem analysis of brain tissue from an HIV-1 subtype C viremic decedent revealed a paucity of infection and pathology2
Fentanyl dysregulates neuroinflammation and disrupts blood-brain barrier integrity in HIV-1 Tat transgenic mice2
The synergistic effect of insomnia and depression on risk of herpes zoster2
Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disorders2
Progressive multifocal leukoencephalopathy, advanced ductal breast carcinoma, systemic sclerosis, and checkpoint inhibitors: a therapeutic dilemma2
Correction to: Reduced neuronal population in the dorsolateral prefrontal cortex in infant macaques infected with simian immunodeficiency virus (SIV)2
Guillain-Barré syndrome associated with COVID-19: a case report study2
Mapping ACE2 and TMPRSS2 co-expression in human brain tissue: implications for SARS-CoV-2 neurological manifestations2
The prevalence and outcomes of depression in older HIV-positive adults in Northern Tanzania: a longitudinal study2
Cognitive screening in HTLV-1–infected people using a self-perceived memory score and auditory P3002
Acute vestibular neuritis: A rare complication after the adenoviral vector-based COVID-19 vaccine2
Longitudinal telomere length profile does not reflect HIV and childhood trauma impacts on cognitive function in South African women2
Improvement in depressive symptoms after antiretroviral therapy initiation in people with HIV in Rakai, Uganda2
Artery of Percheron infarction associated with COVID-19 in the young adult2
Evaluation of iron, ferritin, copper, and ceruloplasmin along with proviral load in human T lymphotropic virus type 1–associated myelopathy2
Cerebrospinal Fluid Biomarkers of Symptomatic Neurosyphilis in People With HIV Compared with Uninfected Individuals2
Correction to: Characteristics of taste dysfunction in COVID‑19 subjects coming from two different countries2
Endolysosome iron restricts Tat-mediated HIV-1 LTR transactivation by increasing HIV-1 Tat oligomerization and β-catenin expression2
Modeling HIV-1 infection and NeuroHIV in hiPSCs-derived cerebral organoid cultures2
Extensive longitudinal myelitis due to cytomegalovirus infection2
T-lymphocyte activation markers in patients with HIV-1-associated neurocognitive disorder2
Immune-mediated cerebellitis following SARS-CoV-2 infection—a case report and review of the literature2
Long-term sequelae of herpes simplex virus encephalitis–related white matter injury: correlation of neuropsychological outcome and diffusion tensor imaging2
Pembrolizumab treatment of inflammatory progressive multifocal leukoencephalopathy: a report of two cases2
Elevated Galectin-9 across the human brain correlates with HIV neuropathology and detrimental cognitive states2
0.066390991210938